Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
BRIGHT MINDS BIOSCIENCES INC.
Bright Minds Biosciences Inc. reported the voting results from its annual general meeting of shareholders held on March 31, 2026. A total of 7,877,637 common shares were voted, representing 80.49% of the outstanding shares, with all resolutions including the election of directors and appointment of auditors being approved.…more
BRIGHT MINDS BIOSCIENCES INC.
Bright Minds Biosciences will participate in the 2026 FPWR Research Symposium and PWS Family Conference to discuss the ongoing Phase 2a NOVA study of BMB-101. Additionally, the company entered into a mutual agreement to rescind the exercise of stock options for 44,500 common shares, which will be returned to the treasury and cancelled.…more
BRIGHT MINDS BIOSCIENCES INC.
Bright Minds Biosciences Inc. has filed a Form S-8 to register 2,415,812 common shares for its stock option and restricted share unit (RSU) plans. This registration covers 1,972,812 shares for future awards and 443,000 shares issuable upon the exercise or settlement of outstanding options and RSUs to incentivize employees and consultants.…more
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Bright Minds Biosciences to Participate in 2026 FPWR Research Symposium…more
Bright Minds Biosciences will attend the 2026 FPWR Research Symposium to discuss the ongoing development of its PWS treatment candidate, BMB-101. As this participation is for networking and information sharing rather than reporting clinical results, the impact on the stock is neutral.…more
●●●●●●●● ●●●●● ●●●●●●
Bright Minds Biosciences announced its participation in upcoming investor events, including the Cantor Global Healthcare Conference. This is a routine corporate update and does not provide immediate material impact on the stock price.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.